Both in Biotechnology
IRulya Therapeutics vs C4 Therapeutics
Over the past year IRLA returned +22.8% and CCCC returned −9.5%; their daily moves had a correlation of 0.48.
IRLA +22.8% CCCC −9.5%Growth of $1, one year, split-adjusted
| Metric | IRLA | CCCC |
|---|---|---|
| Price | $39.78 | $2.77 |
| Market cap | $431.3M | $363.7M |
| Today | +3.78% | −4.15% |
| 1 month | +32.6% | +6.1% |
| 6 months | — | −23.7% |
| Year to date | — | +45.0% |
| 1 year | — | +11.7% |
| Revenue growth (YoY) | — | −24.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −257.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.3× |
| Net cash | — | $205.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 65.7% |
| Short % of float | 14.2% | 47.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).